AGN
Allergan plc
AGN
AGN
Delisted
AGN was delisted on the 8th of May, 2020.
1,006 hedge funds and large institutions have $35.8B invested in Allergan plc in 2018 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 279 increasing their positions, 486 reducing their positions, and 174 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 49 → 33 (-16)
43% less repeat investments, than reductions
Existing positions increased: 279 | Existing positions reduced: 486
Holders
1,006
Holding in Top 10
33
Calls
$745M
Puts
$846M
Top Buyers
| 1 | +$598M | |
| 2 | +$424M | |
| 3 | +$331M | |
| 4 |
KSCM
King Street Capital Management
New York
|
+$169M |
| 5 |
Renaissance Technologies
New York
|
+$107M |
Top Sellers
| 1 | -$248M | |
| 2 | -$196M | |
| 3 | -$149M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$139M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$131M |